AirSculpt Technologies, Inc. Delays Annual Report Filing, Reports Preliminary 2025 Results and Provides Business Update

Key Highlights

• Filing Delay: AirSculpt Technologies, Inc. (NASDAQ: AIRS) announced a delay in filing its Annual Report on Form 10-K for fiscal 2025 and will file a Form 12b-25 to extend the deadline by 15 days.
• Reason for Delay: The extension is required to allow additional time for the company to complete the classification of its inter-company transactions and balances.
• Preliminary 2025 Financial Results: AirSculpt expects fiscal 2025 revenue of approximately \$151.8 million and Q4 2025 revenue of \$33.4 million. Same-store revenue ended the year down by single digits in December, with Q4 same-store revenue down about 16% year-over-year.
• Recent Business Performance: The company’s refreshed marketing strategy delivered positive same-store sales growth in February 2026. Q1 2026 revenue is estimated at \$38.5–\$39.5 million, with same-store revenue expected to be roughly flat at the midpoint.
• Liquidity and Balance Sheet: AirSculpt reports a strong balance sheet and enhanced liquidity.
• Forward-Looking Risks: The company warns that actual results may differ from preliminary estimates due to the ongoing review and a variety of business risks.

Details of the Announcement

On March 16, 2026, AirSculpt Technologies, Inc. disclosed that it will not file its annual report for the fiscal year ended December 31, 2025, by the original deadline. The company will submit a Form 12b-25 to the SEC, granting a 15-day grace period to complete its financial reporting. The delay is specifically attributed to the need for additional time to finalize the classification of inter-company transactions and balances. AirSculpt stated its intention to file the annual report as soon as practicable and within the allowed extension period.

Preliminary Financial Results for Fiscal 2025

• Fiscal 2025 revenue is preliminarily estimated at \$151.8 million.
• Same-store revenue showed improvement, ending the year down by single digits in December — indicating a recovery trend compared to earlier in the year.
• Q4 2025 revenue is estimated at \$33.4 million, with same-store revenue down approximately 16% year-over-year, reflecting ongoing market challenges but also stabilization relative to prior quarters.
• Management emphasized that these results are preliminary and subject to change pending completion of year-end procedures and the audit process.

Business Update and Revenue Trends

• In February 2026, the company’s new marketing strategy began to bear fruit, with positive comparable (same-store) sales growth for the month.
• AirSculpt expects Q1 2026 revenue in the range of \$38.5–\$39.5 million, with same-store revenue approximately flat at the midpoint, signaling stabilization in operating performance and potential for future growth.
• The company highlighted its strong balance sheet and enhanced liquidity as a foundation for continued execution of its business strategy.

Shareholder Considerations and Price-Sensitive Information

• Filing Extension: While AirSculpt expects to file within the 15-day extension, late filings may raise concerns among investors regarding internal controls and oversight of financial reporting. This uncertainty could affect market sentiment and the company’s share price in the near term.
• Preliminary Financials: The reported preliminary results are subject to change. Investors should be aware that the final audited results may differ, potentially affecting valuations and market expectations.
• Improving Trends: The return to positive same-store sales growth in early 2026, following a period of negative trends, may be viewed as a positive inflection point and could have a favorable impact on share value if sustained.
• Operational Risks: The company’s press release included a comprehensive set of forward-looking statements and risk factors, including exposure to macroeconomic shifts, competition (especially from weight-loss drugs), inflation, and execution of its marketing and sales strategies. Any negative developments in these areas could be share price sensitive.

Additional Information

The company’s press release, attached to the SEC Form 8-K, and cautionary statements regarding forward-looking information highlight that all statements other than historical facts are subject to risks and uncertainties. Investors are urged to review the “Risk Factors” section in AirSculpt’s previous SEC filings for a more comprehensive understanding of potential issues that may impact future results.

Contact Information

For investor inquiries, contact Allison Malkin at ICR, Inc. ([email protected]).

Disclaimer: This article is for informational purposes only and does not constitute investment advice. The information is based on preliminary, unaudited results and forward-looking statements, which are subject to change. Investors should consult official filings and their financial advisor before making any investment decisions. AirSculpt Technologies, Inc. disclaims any obligation to update forward-looking statements except as required by law.

View Airsculpt Technologies, Inc. Historical chart here